Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 4/20 | 0.34 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.34 |
| ▸ | FDFT1 | P37268 | 1/20 | 0.33 |
| ▸ | SPHK2 | Q9NRA0 | 4/20 | 0.33 |
| ▸ | SPHK1 | Q9NYA1 | 3/20 | 0.33 |
| ▸ | THRA | P10827 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20275323 | 0.90 | ALOX5 (0.32) | — | |
| SCHEMBL18571376 | 0.81 | SLC7A5 (0.31) | — | |
| SCHEMBL826532 | 0.81 | SLC7A5 (0.50) | — | |
| SCHEMBL14679505 | 0.76 | ANPEP (0.38) | — | |
| SCHEMBL826498 | 0.76 | SLC7A5 (0.51) | — | |
| SCHEMBL14679511 | 0.73 | ANPEP (0.35) | THRATHRB | |
| SCHEMBL826925 | 0.70 | SLC7A5 (0.54) | — | |
| SCHEMBL7020219 | 0.69 | ESR1 (0.48) | — | |
| SCHEMBL1013285 | 0.68 | TAAR1 (0.55) | — | |
| SCHEMBL1013284 | 0.68 | TAAR1 (0.55) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3336103-B1 | ANTIBODIES COMPRISING MULTIPLE SITE-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE | SUTRO BIOPHARMA INC (US) | 2021-03-17 | — | — | EP | disclosed |
| EP-3135690-A1 | MODIFIED FC PROTEINS COMPRISING SITE-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, CONJUGATES OF THE SAME, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE | Sutro Biopharma, Inc. (US) | 2017-03-01 | — | — | EP | disclosed |